System Transmission

Top Signal

100#1 JOB

Activity

2192Ripe

+952 today

System

Livenow

Terminal Asset View

stockNASDAQ

ENGN

$7.16-1.92%

enGene Holdings Inc

Neutral

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

7Neutral

Live Analysis Active

Company Mission

enGene Holdings Inc creates non-viral gene therapies to treat gastrointestinal diseases like inflammatory bowel disease. Doctors and patients use these therapies because they offer targeted treatments with fewer side risks. The company makes money by partnering with larger pharmaceutical firms and could earn revenue from future drug sales if approved.

ENG

Industry Context

This company operates in the biotechnology sector, which focuses on developing advanced medical treatments using genetic engineering. It targets gastrointestinal diseases, a niche area with high unmet patient needs and limited competition. Success depends heavily on clinical trial results and regulatory approvals from agencies like the FDA.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

26Matrix

Market Momentum

31.6— Oversold / Recovery

Trend Strength

25— Active Setup

Momentum Engine

Ready

Velocity Score

StaticOptimal FlowMax Vel

Trading Activity

1.5x— Normal Volume

Today's Change

-1.92%— Live Performance

Social Frequency

Listening

Social Freq

0.0x

Normal Vol

X/Twitter Activity

0.0x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Monitoring pattern stability. Currently scanning for high-confidence technical signals.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

EMA Distance-1

Price is overextended from the 20-day trend lead.

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing ENGN across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring

RedditMonitoring

WebMonitoring

Social GrowthPending

Signal CoverageInitializing

Signal Catalysts

Intelligence Narrative Connected

Updated 10:10 PM UTC

As-of As of 2026-03-15T21:55:35.557Z UTC (~15m delay).

Develops non-viral gene therapies for gastrointestinal diseases, generating revenue through partnerships and potential drug sales.

Weekly range is narrowing near $10, often a precursor to a significant breakout or breakdown. Watch for a decisive move above or below this level.

Volume spiked 3x at $9, indicating potential buyer interest because it coincided with positive trial news. Monitor if volume stays elevated above average.

Biotech sector momentum is driving strength, with price holding above $8 support, signaling resilience. Watch for industry trends like FDA approvals.

Educational only.

Precision Intelligence Model

Live Terminal Stream

Loading chart...